HighTide Therapeutics Inc Sustainability Reports
HighTide Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing multi-targeted therapies for the treatment of chronic metabolic and digestive diseases.
Sector: Manufacturing
Country: China
Exchange: Hong Kong Stock Exchange
FIGI: BBG00L42CZV9
4 reports from 2023 to 2025